Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 4/20 | 0.39 |
| ▸ | FDPS | P14324 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | METAP1 | P53582 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 4/20 | 0.32 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.31 |
| ▸ | GCLC | P48506 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8522272 | 0.79 | LAP3 (0.41) | LAP3FDPSMETAP1MMP1MMP2 | |
| SCHEMBL19212084 | 0.73 | LAP3 (0.39) | LAP3FDPSMETAP1MMP1MMP2 | |
| SCHEMBL3895715 | 0.71 | LMNA (0.43) | LAP3FDPSMETAP1MMP1MMP2 | |
| SCHEMBL8064553 | 0.71 | FDPS (0.33) | LAP3FDPSMMP1MMP2MMP3 | |
| SCHEMBL6516485 | 0.71 | FDPS (0.33) | LAP3FDPSMMP1MMP2MMP3 | |
| SCHEMBL8383008 | 0.70 | LMNA (0.42) | LAP3FDPSMMP1MMP2MMP3 | |
| SCHEMBL2990247 | 0.68 | MMP1 (0.34) | LAP3FDPSMMP1MMP2MMP3 | |
| SCHEMBL4828705 | 0.67 | FDPS (0.40) | FDPS | |
| SCHEMBL6633665 | 0.67 | LAP3 (0.34) | LAP3FDPS | |
| Phosphoric Acid SCHEMBL5462397 | 0.67 | LAP3 (0.38) | LAP3FDPSMETAP1MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114315704-A | Bipyridine compound and synthesis method and application thereof | 西安交通大学 | 2022-04-12 | — | — | CN | disclosed |
| EP-3802547-A1 | PROCESS FOR PRODUCING COMPOUNDS CONTAINING AN OXAZOLOPYRIDINONE FUNCTIONAL GROUP | Biocidal Alternative Solutions (BE) | 2021-04-14 | — | — | EP | disclosed |
| US-7160836-B2 | Materials comprising organic groups containing sulphur and phosphorous bonded to a mineral oxide via oxygen atoms | INSTITUT FRANCOIS DU PETROLE (FR) | 2007-01-09 | — | — | US | disclosed |
| US-20060014635-A1 | Materials comprising organic groups containing sulphur and phosphorous bonded to a mineral oxide via oxygen atoms | FORESTIERE ALAIN | 2006-01-19 | — | — | US | disclosed |
| US-20020128150-A1 | Materials comprising organic groups containing sulphur and phosphorous bonded to a mineral oxide via oxygen atoms | INSTITUT FRANCAIS DU PETROLE (FR) | 2002-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014635-A1 | Materials comprising organic groups containing sulphur and phosphorous bonded to a mineral oxide via oxygen atoms | AP2M1, OPRM1, AP3M1 | LAP3 4447/4885FDPS 2516/4885ALDH1A1 2909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.